RecallReported September 23, 2026
Class II recall by Inventia Healthcare Limited
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
FDA's enforcement report of September 23, 2026 lists a Class II recall by Inventia Healthcare Limited of Kalyan, N/A. Product: Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01. Status: Ongoing.
On the record
- Recalling firm
- Inventia Healthcare Limited
- Location
- Kalyan, N/A
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0852-2026
- Product type
- Drugs
- Brand names
- CHLORTHALIDONE
- Generic names
- CHLORTHALIDONE
- Recall initiated
- 2026-09-03
- Reported by FDA
- 2026-09-23
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Inventia Healthcare Limited
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Inventia Healthcare Limited.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.